Predictive Oncology shares are trading higher after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced a $3 price target.
Portfolio Pulse from Benzinga Newsdesk
Predictive Oncology shares rose after HC Wainwright & Co initiated coverage with a Buy rating and set a $3 price target.
August 19, 2024 | 12:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Predictive Oncology shares increased following HC Wainwright & Co's initiation of coverage with a Buy rating and a $3 price target.
The initiation of coverage by a reputable firm like HC Wainwright & Co with a Buy rating and a specific price target often leads to increased investor interest and buying activity, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100